One Session Virtual Reality During Ongoing Treatment for Anxiety: Feasibility in Children and Adolescents
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 30
- Primary Endpoint
- Willingness to participate in exposure in vivo
Study Overview
Brief Summary
The goal of this study is to evaluate one session with exposure with Virtual Reality (VR) in in children and adolescents, aged 8-18 years with an anxiety disorder. The main questions it aims to answer are:
- What are the expectations of children and adolescents and therapists with VR exposure?
- What is the acceptability of the VR session (positive and negative effects)?
- What are possible working mechanisms of VR exposure? During ongoing treatment, participants will receive a session of exposure with VR.
Detailed Description
Cognitive behavioral therapy is an effective treatment for anxiety disorders, with exposure as the most important working ingredient. Exposure therapy can be challenging to implement in face-to-face settings. Virtual reality (VR) has emerged as a promising tool for delivering exposure therapy.
In the current study, the researchers will examine children and adolescents that will participate in a single session of VR exposure during their regular treatment (n=30). Willingness to participate in exposure in vivo will be assessed directly before and directly after the session. During the session anxiety, idiosyncratic expectations, and self-efficacy will be assessed. Expectations will be measured before the session and acceptability after the session.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 8 Years to 18 Years (Child, Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Children and adolescents 8-18 years old.
- •Meeting Diagnostic and Statistical Manual of Mental Disorders -5 criteria for an anxiety disorder, based on a semi-structured interview (SCID-5 Jr, specific section) or clinical judgment of an experienced and authorized clinician.
Exclusion Criteria
- •Severe psychiatric symptoms other than anxiety disorder interfering with safety or warranting immediate intervention, e.g. psychosis or acute suicidality.
Outcomes
Primary Outcomes
Willingness to participate in exposure in vivo
Time Frame: Directly before and immediately after the session
Participants will be asked about their willingness to participate in exposure in vivo
Secondary Outcomes
- Idiosyncratic expectations(During the session)
- Anxiety(During the session)
- Acceptability(Immediately after the session)
- Expectations of Virtual Reality(Directly before the session)